This Article Full Text Full Text (PDF) All Versions of this Article: 106/13/1659    most recent 01.CIR.0000031567.10814.D8v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mahdi, O. S. Articles by Byrne, G. I. Search for Related Content PubMed PubMed Citation Articles by Mahdi, O. S. Articles by Byrne, G. I. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Coronary Artery Disease Related Collections Risk Factors Chronic ischemic heart disease Epidemiology

(Circulation. 2002;106:1659.)
© 2002 American Heart Association, Inc.

Clinical Investigation and Reports

Serum Immunoglobulin G Antibodies to Chlamydial Heat Shock Protein 60 but Not to Human and Bacterial Homologs Are Associated With Coronary Artery Disease

Olaimatu S. Mahdi, PhD; Benjamin D. Horne, MPH; Kelly Mullen; Joseph B. Muhlestein, MD; Gerald I. Byrne, PhD

From the Department of Medical Microbiology and Immunology, University of Wisconsin, Madison (O.S.M., K.M., G.I.B.) and the LDS Hospital and University of Utah, Salt Lake City, Utah (B.D.H., J.B.M.).

Correspondence to Dr Gerald Byrne, Department of Medical Microbiology and Immunology, 436 SMI, 1300 University Ave, Madison, WI 53706. E-mail gibyrne@ facstaff.wisc.edu

Background— Evidence for an association between Chlamydia pneumoniae infection and coronary artery disease (CAD) has been reported by numerous studies, cross-reactive heat shock protein (Hsp) antibody responses have been causally linked to CAD, and the severity of chlamydial disease pathogenesis correlates with Hsp serology. Our aim was to determine if chlamydial Hsp (cHsp) antibody responses are predictive of CAD.

Methods and Results— Patients were recruited in a case-control study: 250 cases had angiographically significant CAD (stenosis 70%), and 250 controls had normal coronary arteries (stenosis <10%). Serum immunoglobulin G reactivity to Hsp10 and Hsp60 antigens (chlamydial, Escherichia coli, and human), and C pneumoniae whole organisms were measured by ELISA. Univariate analysis confirmed that classical CAD risk factors were predictors of CAD. Univariate analysis showed that cHsp60 (P= 0.001, OR 3.9), cHsp10 (P=0.045, OR 3.8), E coli Hsp60 (P=0.04, OR 1.5) and C pneumoniae (P=0.03, OR 1.8) ELISA optical density (OD) values were significantly different between cases and controls. Multivariate analysis found that only upper-quintile cHsp60 seroreactivity remained a significant predictor of CAD after controlling for classical CAD risk factors and seroreactivity to the other antigens (cHsp60 OD, P=0.005, OR 3.9 per OD unit; cHsp60 quintile, 5 versus 1 to 4; P=0.01, OR 2.1).

Conclusions— The presence of elevated anti-cHsp60 immunoglobulin G antibodies, but not anti-human or anti–E coli homologs, was independently associated with CAD. This finding argues against previous suggestions that cross-reactive or autoimmune Hsp60 responses may contribute to disease progression. High anti-cHsp60 antibody response appears to identify the subset of patients with chlamydial infection and significant CAD.

Key Words: coronary disease • antibodies • atherosclerosis • proteins

This article has been cited by other articles:

				P. N. Baird, L. D. Robman, A. J. Richardson, P. N. Dimitrov, G. Tikellis, C. A. McCarty, and R. H. Guymer Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection Hum. Mol. Genet., May 1, 2008; 17(9): 1299 - 1305. [Abstract] [Full Text] [PDF]

				L. Robman, O. S. Mahdi, J. J. Wang, G. Burlutsky, P. Mitchell, G. Byrne, R. Guymer, and H. Taylor Exposure to Chlamydia pneumoniae Infection and Age-Related Macular Degeneration: The Blue Mountains Eye Study Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4007 - 4011. [Abstract] [Full Text] [PDF]

				V P van Halm, M C Slot, M T Nurmohamed, J W Cohen Tervaert, B A C Dijkmans, and A E Voskuyl Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis Ann Rheum Dis, May 1, 2006; 65(5): 590 - 594. [Abstract] [Full Text] [PDF]

				A G Pockley and J Frostegard Heat shock proteins in cardiovascular disease and the prognostic value of heat shock protein related measurements Heart, September 1, 2005; 91(9): 1124 - 1126. [Abstract] [Full Text] [PDF]

				D H Birnie, L E Vickers, W S Hillis, J Norrie, and S M Cobbe Increased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest pain Heart, September 1, 2005; 91(9): 1148 - 1153. [Abstract] [Full Text] [PDF]

				K. Mandal, M. Jahangiri, M. Mukhin, J. Poloniecki, A. J. Camm, and Q. Xu Association of Anti-Heat Shock Protein 65 Antibodies With Development of Postoperative Atrial Fibrillation Circulation, October 26, 2004; 110(17): 2588 - 2590. [Abstract] [Full Text] [PDF]

				C. Buono, H. Pang, Y. Uchida, P. Libby, A. H. Sharpe, and A. H. Lichtman B7-1/B7-2 Costimulation Regulates Plaque Antigen-Specific T-Cell Responses and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice Circulation, April 27, 2004; 109(16): 2009 - 2015. [Abstract] [Full Text] [PDF]

				J. P. Higgins Chlamydia pneumoniae and Coronary Artery Disease: The Antibiotic Trials Mayo Clin. Proc., March 1, 2003; 78(3): 321 - 332. [Abstract] [PDF]

				M. V. Kalayoglu, P. Libby, and G. I. Byrne Chlamydia pneumoniae as an Emerging Risk Factor in Cardiovascular Disease JAMA, December 4, 2002; 288(21): 2724 - 2731. [Abstract] [Full Text] [PDF]